-
Gastrointestinal Stromal Tumor Market Size in the 7MM was USD 467 Million in 2021, estimates DelveInsight
26 Mar 2024 06:47 GMT
… .
Gastrointestinal Stromal Tumor Drugs Uptake
Arog Pharmaceutical’s Crenolanib is a small molecule investigational drug candidate … US FDA had granted Fast Track designation for Crenolanib to treat patients …
-
CStone Pharmaceuticals Reports 2023 Annual Results and Business Updates
27 Mar 2024 16:39 GMT
… challenges for CStone Pharmaceuticals. We have made … research and development of innovative drugs to meet … the treatment of adults with unresectable or metastatic gastrointestinal stromal tumor … experience in innovative drug development, clinical research, and …
-
Ascentage Pharma Announces 2023 Annual Results
27 Mar 2024 16:39 GMT
… Developed Innovative Drugs, olverembatinib was included into the 2022 National Reimbursement Drug … Pharma released results from three clinical studies of lisaftoclax, for the treatment … dehydrogenase (SDH)-deficient gastrointestinal stromal tumor (GIST), thus …
-
Mesenchymal Tumor Of The Gastrointestinal Tract drugs in development, 2023
21 Mar 2024 05:55 GMT
… are represented by gastrointestinal stromal tumors (GISTs), which … drugs offers detailed profiles of pharmaceutical drugs in … all stages of pre-clinical and clinical development … repositories of pharmaceutical drug information offered …
-
Nimble Therapeutics Adds Peptide Drug Development Expertise to Board of Directors
19 Mar 2024 15:20 GMT
… deep entrepreneurial and drug development track records that … Qinlock® for the treatment of gastrointestinal stromal tumors. Before founding … companies including Millennium Pharmaceuticals, Amgen Inc. … developed novel small molecule or peptide-based drugs …
-
Gastrointestinal Stromal Tumor Market to Reach US$ 810.2 Million by 2034
01 Mar 2024 11:20 GMT
… development of targeted therapies like tyrosine kinase inhibitors, which have revolutionized gastrointestinal stromal tumor treatment … drugs.
In-Market Drugs:
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug …
-
IDRx Appoints David P. Kerstein, M.D., as Chief Medical Officer
27 Mar 2024 12:24 GMT
… to transforming cancer treatment with purpose-built … Pharmaceuticals, Inc., where he led the clinical development … University.
About GIST
Gastrointestinal stromal tumors (GIST) are the … and drug-resistant mutations of KIT in gastrointestinal stromal tumor (GIST …
-
Promising Results: Combination Drug Therapy for Treatment-Resistant Cancer
02 Mar 2024 16:00 GMT
… Cancer Center.
Both drugs interfere with cell growth … hard to treat.
“Every single clinical trial done to … such as colorectal and gastrointestinal stromal tumors.
Initial experiments in MPNST … and compositions for MPNST treatment. Pratilas has received …
-
Dabrafenib mesylate by Novartis for Gastrointestinal Stromal Tumor (GIST): Likelihood of Approval
21 Dec 2023 23:34 GMT
… historical drug development data. Attributes of the drug, … detected by an FDA-Approved test. … tract cancer (BTC), gastrointestinal stromal tumor (GIST), adenocarcinoma of … pharmaceutical products and eye care products. It provides drugs for the treatment …
-
Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis
22 Feb 2024 19:30 GMT
… company focused on developing precision therapies for … previously with other treatment options in this … fighting systemic mastocytosis and gastrointestinal stromal tumors.” Patient Demographics
SUMMIT … led to discontinuation. Pharmacodynamic Data
Thirty-four …